Zobrazeno 1 - 10
of 25
pro vyhledávání: '"TASUKU HIROSHIGE"'
Autor:
Kosuke Ueda, Keiichiro Uemura, Naoki Ito, Yuya Sakai, Satoshi Ohnishi, Hiroki Suekane, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Sachiko Ogasawara, Hirohisa Yano, Tsukasa Igawa
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 1701-1712 (2024)
Immuno-oncology (IO) combination therapy is the first-line treatment for advanced renal cell carcinoma (RCC). However, biomarkers for predicting the response to IO combination therapy are lacking. Here, we investigated the association between the exp
Externí odkaz:
https://doaj.org/article/11f53d13330b4e1285ae6a5190539e9a
Autor:
Tasuku Hiroshige, Kei-Ichiro Uemura, Shingo Hirashima, Akinobu Togo, Keisuke Ohta, Kei-Ichiro Nakamura, Tsukasa Igawa
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The present study aimed to explore the three-dimensional (3D) ultrastructure of interstitial cells (ICs) within the lamina propria of the murine vas deferens and the spatial relationships between epithelial cells and surrounding cells. Focus
Externí odkaz:
https://doaj.org/article/9e2eca84c3964ce8b935f29bc869c649
Autor:
Tasuku Hiroshige, Kei-Ichiro Uemura, Shingo Hirashima, Kiyosato Hino, Akinobu Togo, Keisuke Ohta, Tsukasa Igawa, Kei-Ichiro Nakamura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Platelet-derived growth factor receptor-α (PDGFRα)-positive interstitial cells (ICs) are widely distributed in various organs and may be involved in the motility of various tubular organs. We, for the first time, aimed to investigate the d
Externí odkaz:
https://doaj.org/article/c60511263b4d4fe9a8f6f45f4fa5372a
Autor:
Kei-ichiro Uemura, Yoshihiro Miyazono, Tasuku Hiroshige, Keisuke Ohta, Kosuke Ueda, Kiyoaki Nishihara, Makoto Nakiri, Shingo Hirashima, Tsukasa Igawa, Kei-ichiro Nakamura
Publikováno v:
Microscopy and Microanalysis. 29:832-840
The ultrastructure of the nuclear envelope (NE) and redundant NE (RNE) of the spermatozoon cannot be observed in detail using conventional electron microscopy. Thus, this study aimed to employ transmission electron microscopy (TEM) and focused ion be
Autor:
Kosuke Ueda, Naoyuki Ogasawara, Naoki Ito, Satoshi Ohnishi, Hiroki Suekane, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Keiichiro Uemura, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Tsukasa Igawa
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 6; Pages: 2417
Nivolumab and ipilimumab (NIVO + IPI) is standard therapy for patients with advanced renal cell carcinoma (RCC). Absolute lymphocyte count (ALC) is a valuable prognostic factor in patients with various cancers treated with immune checkpoint inhibitor
Autor:
Naohiro, Fujimoto, Akinori, Minato, Tsukasa, Igawa, Tasuku, Hiroshige, Wataru, Obara, Atsushi, Fukuda, Yujiro, Nagata, Yui, Mizushima, Ikko, Tomisaki, Kenichi, Harada
Publikováno v:
Anticancer Research. 42:3041-3047
Although the sequential use of abiraterone and enzalutamide is not recommended because of possible cross-resistance, many patients with metastatic castration-resistant prostate cancer (mCRPC) are receiving sequential abiraterone and enzalutamide in t
Autor:
Tokumasa Hayashi, Tsukasa Igawa, Kei-ichiro Uemura, Keisuke Ohta, Shingo Hirashima, Tasuku Hiroshige, Makoto Nakiri, Tomonoshin Kanazawa, Kosuke Ueda, Kei-ichiro Nakamura
Publikováno v:
Journal of Molecular Histology. 52:1205-1214
The aim of this study is to clarify the disibution, shape, and immunohistochemical characteristics of serotonin-immunoreactive neuroendocrine cells (SIR-NECs) in mouse prostate and in the surrounding genital organs by histological and immunohistochem
Autor:
Kosuke Ueda, Hirofumi Kurose, Makoto Nakiri, Katsuaki Chikui, Tsukasa Igawa, Shigetaka Suekane, Tasuku Hiroshige, Mitsunori Matsuo, Keiichiro Uemura, Kiyoaki Nishihara, Naoyuki Ogasawara
Publikováno v:
Japanese Journal of Clinical Oncology. 52:179-186
Objective Programmed cell death-1 antibody therapy has demonstrated improved progression-free survival and overall survival in patients with metastatic renal cell carcinoma. However, there are limited studies on biomarkers that can predict the effica
Autor:
KOSUKE UEDA, SHIGETAKA SUEKANE, HIROFUMI KUROSE, NAOKI ITO, NAOYUKI OGASAWARA, TASUKU HIROSHIGE, KATSUAKI CHIKUI, KAZUHISA EJIMA, KEIICHIRO UEMURA, MAKOTO NAKIRI, KIYOAKI NISHIHARA, MITSUNORI MATSUO, TSUKASA IGAWA
Publikováno v:
Anticancer research. 42(9)
Immuno-oncology (IO) combination therapy has become the standard of treatment for advanced renal cell carcinoma (RCC). In this retrospective study, we compared the efficacy of first-line molecular targeted therapy (MTT), administered as monotherapy,
Autor:
TASUKU HIROSHIGE, NAOYUKI OGASAWARA, HISAJI KUMAGAE, KOSUKE UEDA, KATSUAKI CHIKUI, KEI-ICHIRO UEMURA, KIYOAKI NISHIHARA, MAKOTO NAKIRI, MITSUNORI MATSUO, SHIGETAKA SUEKANE, TSUKASA IGAWA
Publikováno v:
In Vivo; May/Jun2023, Vol. 37 Issue 3, p1266-1274, 9p